	税引前利益		日付
Acadia Pharmaceuticals	USD 46.47M	42.49M	2026-06
Adma Biologics	USD 57.13M	4.47M	2026-03
ALKERMES	USD -61.93M	122.3M	2026-03
Alterity Therapeutics Limited	AUD -6.26M	1.52M	2025-12
AstraZeneca	USD 4.81B	894M	2026-06
BioCryst Pharmaceuticals	USD 248.02M	235.89M	2025-12
Bristol-Myers Squibb	USD 4.99B	1.75B	2026-06
Cipla	INR 10.82B	3.33B	2026-06
Clal Biotechnology	ILS 86.82M	17.9M	2022-12
Compugen	USD -7.66M	64.51M	2026-03
CSL	USD 2.61B	1.21B	2025-12
Eli Lilly	USD 8.85B	583.8M	2026-03
GlaxoSmithKline	GBP 2.68B	532M	2026-06
Grifols	EUR 257.85M	190.87M	2024-12
Halozyme Therapeutics	USD 180.33M	281.18M	2026-03
Ionis Pharmaceuticals	USD -114M	21M	2026-06
J&J	USD 8.66B	839M	2026-06
Merck	USD -3.53B	6.95B	2026-03
Minerva Neurosciences	USD 22.51M	30.74M	2024-09
Neurocrine Biosciences	USD 246.8M	7.4M	2026-03
Novartis	USD 4.27B	430M	2026-06
Novavax	USD 17.9M	220.94M	2025-12
Pfizer	USD -653M	5.84B	2026-06
Roche Holding	CHF 11.17B	6.38B	2026-06
Sanofi	EUR 837M	1.17B	2026-06
Takeda	JPY 162.72B	215.2B	2026-06
Vanda Pharmaceuticals	USD -22.92M	16.68M	2024-12